OrganovoCompany Review & Valuation

ONVO
Nasdaq
Latest Price
8.58USD
Market Capitalization
1,119.67mUSD

About Organovo Holdings, Inc.

Organovo Holdings, Inc., a biotechnology company, provides therapeutic and drug profiling capabilities based on its 3D bioprint tissues that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrShow moreication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat a range of rare, life-threatening diseases. In addition, the company offers preclinical in vitro disease modeling platforms, including a range of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis conditions. Further, it involved in various programs to develop its NovoTissues transplantable tissues to address various serious unmet medical needs in adult and pediatric populations primarily focusing on liver disease. The company was founded in 2007 and is headquartered in San Diego, California.Show less

Industry
Diagnostics & Research
HQ Location
San Diego, California
Wikipedia

Stock Price

Price data not available for Organovo.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Thermo Fisher
Quest Diagnostics
DiaSorin
Danaher

back to top